Cigna Group Stock: Is CI Outperforming the Healthcare Sector?
Written by Emily J. Thompson, Senior Investment Analyst
Source: NASDAQ.COM
Cigna Group Overview: Cigna Group, valued at $84.8 billion, operates globally with two main platforms and has approximately 182 million customer relationships, but its stock has seen a decline of 16.4% from its 52-week high.
Stock Performance and Analyst Outlook: Despite recent fluctuations and not meeting Wall Street expectations, Cigna's shares rose due to strong revenue growth, leading analysts to maintain a "Strong Buy" rating, with the stock trading below the mean price target of $365.24.
Analyst Views on IXJ
Wall Street analysts forecast IXJ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IXJ is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 100.020
Low
Averages
High
Current: 100.020
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
